Hi Everyone,

It is often said, "There are no scientific studies regarding the
efficacy of Low Dose Naltrexone (LDN) in the treatment of multiple
sclerosis." That statement is false.

The fact is, the very first randomized, placebo-controlled, double-blind
study of LDN in the treatment of MS took place with 60 patients at the
Evers Neurological Clinic in Germany during 2004 and 2005.

Unfortunately, the study was flawed both in terms of LDN administration
time and dosage. Even so, definite benefit was observed in about a third
of study participants.

For a summary of the study results, visit

http://www.webspawner.com/users/germanldnstudy/index.html

With best wishes,

Dudley Delany


http://profiles.yahoo.com/dudley_delany